Clinical Trial Update: Korean Post-marketing Surveillance for Xeljanz XR

View source ↗

Summary

Korean post-marketing surveillance study for Xeljanz XR (tofacitinib extended-release) is currently recruiting to monitor safety and effectiveness in rheumatoid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• XELJANZ XR (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis | Status: RECRUITING